Spartan Peptides LLC
All dosage protocols

Kisspeptin dosage chart

10 mg Vial

Kisspeptin is dosed at 100 mcg–200 mcg daily via subcutaneous injection in educational protocols. A 10 mg vial reconstituted with bacteriostatic water yields about 3.33 mg/mL. This information is for research and educational use only.

Reconstitute
Add 3.0 mL bacteriostatic water → ~3.33 mg/mL concentration.
Typical daily range
100–200 mcg once daily (gradual titration).
Easy measuring
At 3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.3 mcg on a U‑100 insulin syringe.
Storage
Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.

Dosing schedule

WeekDaily Dose (mcg)Units (per injection) (mL)
Weeks 1–2100 mcg3 units (0.03 mL)
Weeks 3–8 (or 3–12)200 mcg6 units (0.06 mL)

Reconstitution steps

  1. 1Draw 3.0 mL bacteriostatic water with a sterile syringe.
  2. 2Inject slowly down the vial wall; avoid foaming.
  3. 3Gently swirl/roll until dissolved (do not shake).
  4. 4Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Important Notes

Practical considerations for consistency and safety.

  • Use new sterile insulin syringes; dispose in a sharps container.
  • Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
  • Inject slowly; wait a few seconds before withdrawing the needle.
  • Document daily dose and site rotation to maintain consistency.
  • Discard bacteriostatic water after 28 days once opened.

How This Works

Kisspeptin is an upstream trigger for the reproductive hormone cascade. Upon subcutaneous injection, kisspeptin rapidly binds to kisspeptin receptors (GPR54) on GnRH neurons in the hypothalamus, causing immediate release of GnRH. This in turn stimulates the anterior pituitary to secrete LH and FSH, which act on the gonads to boost sex steroid production and support gametogenesis. Importantly, kisspeptin’s action is GnRH-dependent—if GnRH release is blocked, kisspeptin cannot induce LH/FSH secretion. This confirms that kisspeptin works by unlocking the body’s own GnRH stores, providing a more physiologic pattern of hormone release compared to direct GnRH or hCG administration.

Potential Benefits & Applications

Research on kisspeptin has revealed multiple potential benefits for reproductive health.

  • Physiological Sex Hormone Stimulation: Increases endogenous testosterone and estrogen levels by amplifying the body’s own LH/FSH signals without suppressing the HPG axis.
  • Fertility Restoration: Shows promise in functional hypothalamic amenorrhea by rekindling GnRH/LH pulsatility and resuming menstrual cycles.
  • IVF Ovulation Trigger: Can induce robust LH surge to mature oocytes while potentially lowering the risk of ovarian hyperstimulation syndrome compared to traditional hCG triggers.
  • Safety Profile: Generally well tolerated; occasional mild injection-site reactions (redness/itch) may occur with subcutaneous administration.

Lifestyle Factors

Complementary strategies for optimal outcomes.

  • Maintain adequate nutrition and healthy body weight to support endogenous hormone production.
  • Prioritize sleep and stress management, as these factors significantly impact the HPG axis.
  • Monitor for changes in reproductive function or hormone-related symptoms.
  • Consider combining with appropriate lifestyle interventions for conditions of hypothalamic suppression.

Injection Technique

General subcutaneous guidance from clinical best‑practice resources.

  • Clean the vial stopper and skin with alcohol; allow to dry completely.
  • Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue (45° for thin individuals, 90° with adequate fat).
  • Do not aspirate for subcutaneous injections; inject slowly and steadily.
  • Rotate sites systematically (abdomen at least 2 inches from navel, outer thighs, upper arms, upper buttocks) to avoid tissue irritation.
  • Use a new sterile syringe for each injection; dispose of used syringes in a proper sharps container.

important-note

This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment.

Kisspeptin dosage FAQs

How much bacteriostatic water do you use to reconstitute Kisspeptin?

Add 3.0 mL bacteriostatic water → ~3.33 mg/mL concentration. for a 10 mg Vial vial. Add the water slowly against the inside wall of the vial and swirl — never shake — until the powder fully dissolves.

What does the Kisspeptin dosing schedule look like?

Weeks 1–2 — 100 mcg — 3 units (0.03 mL); Weeks 3–8 (or 3–12) — 200 mcg — 6 units (0.06 mL). The full table above lists every step with matching syringe units.

What are the mixing steps for Kisspeptin?

Draw 3.0 mL bacteriostatic water with a sterile syringe. Inject slowly down the vial wall; avoid foaming. Gently swirl/roll until dissolved (do not shake).

How should reconstituted Kisspeptin be stored?

Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles..

How many insulin syringe units equal a Kisspeptin dose?

Units depend on the water volume you used. Divide your target dose by the vial concentration to get millilitres, then multiply by 100 — 1 unit on a U-100 insulin syringe is 0.01 mL. The Spartan Peptides reconstitution calculator does this conversion for you.

Is Kisspeptin approved for human use?

No. Kisspeptin is sold and referenced strictly as a research chemical. Nothing on this page is medical advice and the material is not for human consumption.

Educational and research information only. Not medical advice, not for human consumption. Values are reference figures — always verify your own math with the reconstitution calculator.

On any insulin syringe, 1 unit = 0.01 mL, so unit counts above hold across brands.